173 related articles for article (PubMed ID: 32540433)
1. Targeting post-translational modification of transcription factors as cancer therapy.
Qian M; Yan F; Yuan T; Yang B; He Q; Zhu H
Drug Discov Today; 2020 Aug; 25(8):1502-1512. PubMed ID: 32540433
[TBL] [Abstract][Full Text] [Related]
2. Current strategies and progress for targeting the "undruggable" transcription factors.
Zhuang JJ; Liu Q; Wu DL; Tie L
Acta Pharmacol Sin; 2022 Oct; 43(10):2474-2481. PubMed ID: 35132191
[TBL] [Abstract][Full Text] [Related]
3. Targeting post-translational modifications of histones for cancer therapy.
Hsu YC; Hsieh YH; Liao CC; Chong LW; Lee CY; Yu YL; Chou RH
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):69-84. PubMed ID: 26518898
[TBL] [Abstract][Full Text] [Related]
4. Regulation of transcription factor activity by interconnected post-translational modifications.
Filtz TM; Vogel WK; Leid M
Trends Pharmacol Sci; 2014 Feb; 35(2):76-85. PubMed ID: 24388790
[TBL] [Abstract][Full Text] [Related]
5. Role of transcription factor acetylation in the regulation of metabolic homeostasis.
Park JM; Jo SH; Kim MY; Kim TH; Ahn YH
Protein Cell; 2015 Nov; 6(11):804-13. PubMed ID: 26334401
[TBL] [Abstract][Full Text] [Related]
6. Modifications in the cellular proteome and their clinical application.
Elguero B; Gonilski Pacin D; Cárdenas Figueroa C; Fuertes M; Arzt E
Medicina (B Aires); 2019; 79(Spec 6/1):570-575. PubMed ID: 31864228
[TBL] [Abstract][Full Text] [Related]
7. BET-Family Bromodomains Can Recognize Diacetylated Sequences from Transcription Factors Using a Conserved Mechanism.
Patel K; Solomon PD; Walshe JL; Ford DJ; Wilkinson-White L; Payne RJ; Low JKK; Mackay JP
Biochemistry; 2021 Mar; 60(9):648-662. PubMed ID: 33620209
[TBL] [Abstract][Full Text] [Related]
8. Post-translational modification of SOX family proteins: Key biochemical targets in cancer?
Williams CAC; Soufi A; Pollard SM
Semin Cancer Biol; 2020 Dec; 67(Pt 1):30-38. PubMed ID: 31539559
[TBL] [Abstract][Full Text] [Related]
9. The posttranslational modifications of Hippo-YAP pathway in cancer.
Yan F; Qian M; He Q; Zhu H; Yang B
Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129397. PubMed ID: 31306710
[TBL] [Abstract][Full Text] [Related]
10. Post-translational modification of transcription factors: mechanisms and potential therapeutic interventions.
Planey SL; Kumar R; Arnott JA
Curr Mol Pharmacol; 2013 Nov; 6(3):173-82. PubMed ID: 24694345
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
12. Post-Translational Modifications of Transcription Factors Harnessing the Etiology and Pathophysiology in Colonic Diseases.
Hsu CY; Fu SH; Chien MW; Liu YW; Chen SJ; Sytwu HK
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32369982
[TBL] [Abstract][Full Text] [Related]
13. Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets.
Tate EW; Soday L; de la Lastra AL; Wang M; Lin H
Nat Rev Cancer; 2024 Apr; 24(4):240-260. PubMed ID: 38424304
[TBL] [Abstract][Full Text] [Related]
14. Post-translational modifications influence transcription factor activity: a view from the ETS superfamily.
Tootle TL; Rebay I
Bioessays; 2005 Mar; 27(3):285-98. PubMed ID: 15714552
[TBL] [Abstract][Full Text] [Related]
15. Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis.
Thompson LL; Guppy BJ; Sawchuk L; Davie JR; McManus KJ
Cancer Metastasis Rev; 2013 Dec; 32(3-4):363-76. PubMed ID: 23609752
[TBL] [Abstract][Full Text] [Related]
16. Posttranslational modifications of RUNX1 as potential anticancer targets.
Goyama S; Huang G; Kurokawa M; Mulloy JC
Oncogene; 2015 Jul; 34(27):3483-92. PubMed ID: 25263451
[TBL] [Abstract][Full Text] [Related]
17. Regulating the regulators: modulators of transcription factor activity.
Everett L; Hansen M; Hannenhalli S
Methods Mol Biol; 2010; 674():297-312. PubMed ID: 20827600
[TBL] [Abstract][Full Text] [Related]
18. Lysine methylation of transcription factors in cancer.
Han D; Huang M; Wang T; Li Z; Chen Y; Liu C; Lei Z; Chu X
Cell Death Dis; 2019 Mar; 10(4):290. PubMed ID: 30926778
[TBL] [Abstract][Full Text] [Related]
19. Covalent Modifications of RUNX Proteins: Structure Affects Function.
Blumenthal E; Greenblatt S; Huang G; Ando K; Xu Y; Nimer SD
Adv Exp Med Biol; 2017; 962():33-44. PubMed ID: 28299649
[TBL] [Abstract][Full Text] [Related]
20. Post-Translational Modification Control of Innate Immunity.
Liu J; Qian C; Cao X
Immunity; 2016 Jul; 45(1):15-30. PubMed ID: 27438764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
